Hotline:
+ 49 (0) 2204 2918806

Studien in der Kategorie Arzneimittel

Artikel 1 bis 10 von 8440

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 844
  1. Preis netto*
    Jahr
  2. 1.420,56 $
    2014
    Für diese Studie liegt keine Bewertung vor.

    Gilead Sciences, Inc. - Product Pipeline Review - 2014

    Global Markets Direct
    140 Seiten
    Global Markets Direct’s, ‘Gilead Sciences, Inc. - Product Pipeline Review - 2014’, provides an overview of the Gilead Sciences, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Gilead Sciences, Inc.’s, complete with comparativ
    Englisch | Zukunftsanalyse | Artikelnummer: 394228
  3. 2.367,60 $
    2015
    Für diese Studie liegt keine Bewertung vor.

    Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2015

    GlobalData
    195 Seiten
    GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Non-Alcoholic Steatohepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Alcoholic Steatohepatitis. Report includes an overview of trial numbers and
    Englisch | Marktstudie | Artikelnummer: 987689513
  4. 1.894,08 $
    2013
    Für diese Studie liegt keine Bewertung vor.

    Malignant Glioma - Pipeline Review, H2 2013

    Global Markets Direct
    64 Seiten
    Global Markets Direct’s, 'Malignant Glioma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Malignant Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key pla
    Englisch | Zukunftsanalyse | Artikelnummer: 386263
  5. 236,76 $
    Für diese Studie liegt keine Bewertung vor.

    Generics in Spain

    MarketLine
    42 Pages
    Introduction Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
    Englisch | Industry Profile | Artikelnummer: 46153
  6. 1.420,56 $
    2012
    Für diese Studie liegt keine Bewertung vor.

    Ajinomoto Pharmaceuticals Co., Ltd. – Product Pipeline Review – 2012

    Global Markets Direct
    35 Seiten
    Introduction Global Market Direct’s pharmaceuticals report, “Ajinomoto Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2012” provides data on the Ajinomoto Pharmaceuticals Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features
    Englisch | Report | Artikelnummer: 318169
  7. 236,76 $
    2014
    Für diese Studie liegt keine Bewertung vor.

    BioNeutral Group, Inc. (BONU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 seiten
    BioNeutral Group, Inc. (BioNeutral) is a chemical company. The company develops and markets infection and odor control products. Its products include Ygiene 206 Sterilant, Ogiene Multipurpose Cleaner, Ogiene Odor Eliminator, and Ogiene Sports Odor Eliminator. BioNeutral’s products are used to remove noxious odors, stains, dirt and grime
    Englisch | Zukunftsanalyse | Artikelnummer: 159660
  8. 3.309,90 $
    2014
    Für diese Studie liegt keine Bewertung vor.

    Saphris (Schizophrenia) - Forecast and Market Analysis to 2022

    GlobalData
    44 Seiten
    Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have
    Englisch | Zukunftsanalyse | Artikelnummer: 402861
  9. 468,78 $
    2013
    Für diese Studie liegt keine Bewertung vor.

    ICT budget forecasts in Large Finnish Media Companies - Estimated ICT budget breakdowns in 2013

    Kable Global ICT Intelligence
    19 Seiten
    SynopsisThis report illustrates how Kable expects Large Finnish Media Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.SummaryWhy was the report written?This report presents the output from Kable's ICT spend prediction statistic
    Englisch | Databook | Artikelnummer: 332238
  10. 2.367,60 $
    2013
    Für diese Studie liegt keine Bewertung vor.

    Ireland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2018

    Global Markets Direct
    196 Seiten
    Introduction "Ireland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Ireland Wound Care Management market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within e
    Englisch | Report | Artikelnummer: 318809
  11. 1.894,08 $
    2013
    Für diese Studie liegt keine Bewertung vor.

    Fatigue – Pipeline Review, H1 2013

    Global Markets Direct
    61 Seiten
    Introduction Global Markets Direct’s, 'Fatigue - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Fatigue, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players
    Englisch | Report | Artikelnummer: 324411

Artikel 1 bis 10 von 8440

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 844